Cargando…

Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?

PURPOSE: Androgen receptor (AR) has been shown to have prognostic implication on breast cancer (BC). Data on the biological features of African BCs are poor. We decided for the first time to compare AR expression of Tanzanian and Italian BC patients. PATIENTS AND METHODS: Of the 69 consecutive patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bravaccini, Sara, Ravaioli, Sara, Amadori, Dino, Scarpi, Emanuela, Puccetti, Maurizio, Rocca, Andrea, Tumedei, Maria Maddalena, Masalu, Nestory, Kahima, Jackson, Pangan, Akwilina, Faustine, Lucas, Farolfi, Alberto, Maltoni, Roberta, Bonafè, Massimiliano, Serra, Patrizia, Bronte, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885470/ https://www.ncbi.nlm.nih.gov/pubmed/29651273 http://dx.doi.org/10.3389/fendo.2018.00137

Ejemplares similares

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?
por: Bronte, Giuseppe, et al.
Publicado: (2018)

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
por: Bronte, Giuseppe, et al.
Publicado: (2019)

Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania
por: Masalu, Nestory, et al.
Publicado: (2017)

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
por: Bronte, Giuseppe, et al.
Publicado: (2018)

The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial
por: Bravaccini, Sara, et al.
Publicado: (2020)

Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients
por: Rambau, Peter, et al.
Publicado: (2014)

Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in early breast cancer
por: Maltoni, Roberta, et al.
Publicado: (2017)

Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway
por: Amadori, Dino, et al.
Publicado: (2017)

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer
por: Maltoni, Roberta, et al.
Publicado: (2020)

The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects
por: Bravaccini, Sara, et al.
Publicado: (2021)

Setting Up a Medical Oncology Educational Program in Sub-Saharan Africa
por: Bravaccini, Sara, et al.
Publicado: (2021)

Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ
por: Farolfi, Alberto, et al.
Publicado: (2020)

New Biomarkers to Predict the Evolution of In Situ Breast Cancers
por: Bravaccini, S., et al.
Publicado: (2014)

Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology
por: Ravaioli, Sara, et al.
Publicado: (2016)

Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold
por: Maltoni, Roberta, et al.
Publicado: (2020)

Predictive Role of Telomerase Activity in the Clinical Outcome of Patients with Benign Lesions of the Uterine Cervix or CIN
por: Bravaccini, Sara, et al.
Publicado: (2012)

Evaluating the appropriateness of chemotherapy in a low‐resource cancer centre in sub‐Saharan Africa
por: Serra, Patrizia, et al.
Publicado: (2019)

PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis
por: Bravaccini, Sara, et al.
Publicado: (2018)

Spotlight on PSMA as a new theranostic biomarker for bladder cancer
por: Tumedei, Maria Maddalena, et al.
Publicado: (2021)

Androgen receptor in breast cancer: The “5W” questions
por: Ravaioli, Sara, et al.
Publicado: (2022)

The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer
por: Bronte, Giuseppe, et al.
Publicado: (2021)

Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota
por: Pirini, Francesca, et al.
Publicado: (2023)

Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?
por: Maltoni, Roberta, et al.
Publicado: (2021)

Clinicopathological patterns and challenges of management of colorectal cancer in a resource-limited setting: a Tanzanian experience
por: Chalya, Phillipo L, et al.
Publicado: (2013)

Why the complications of COVID-19 patients differ in elderly and young cancer patients
por: Bravaccini, Sara, et al.
Publicado: (2022)

Psychometric properties and the prevalence, intensity and causes of oral impacts on daily performance (OIDP) in a population of older Tanzanians
por: Kida, IA, et al.
Publicado: (2006)

Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer
por: Pietri, Elisabetta, et al.
Publicado: (2018)

The current role of telomerase in the diagnosis of bladder cancer
por: Bravaccini, Sara, et al.
Publicado: (2009)

Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
por: Cortesi, Michela, et al.
Publicado: (2021)

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence
por: Rocca, Andrea, et al.
Publicado: (2018)

Marjolin's ulcers at a university teaching hospital in Northwestern Tanzania: a retrospective review of 56 cases
por: Chalya, Phillipo L, et al.
Publicado: (2012)

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
por: Bravaccini, Sara, et al.
Publicado: (2019)

Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
por: Bravaccini, Sara, et al.
Publicado: (2021)

Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer
por: Maltoni, Roberta, et al.
Publicado: (2022)

Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence
por: Rengucci, Claudia, et al.
Publicado: (2014)

Usefulness of Immunological Detection of the Human Telomerase Reverse Transcriptase
por: Volpi, Annalisa, et al.
Publicado: (2005)

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience
por: Palleschi, Michela, et al.
Publicado: (2020)

Oral health behavior patterns among Tanzanian university students: a repeat cross-sectional survey
por: Åstrøm, Anne Nordrehaug, et al.
Publicado: (2001)

TMB in NSCLC: A Broken Dream?
por: Bravaccini, Sara, et al.
Publicado: (2021)

Dental Caries Pattern Amongst Tanzanian Children: National Oral Health Survey
por: Mbawalla, Hawa Shariff, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jnr8bui57bjs6gkpp7tif7r9iq